Bench to bedside: CAR-T cells

Programme stream(s): Cancer discovery / underpinning research , Treatment
Programme session type(s): Parallel session

Chair: John Maher, Kings College London
Speaker: Renier Brentjens, Memorial Sloan Kettering Cancer Center, USA
Speaker: Reuben Benjamin, Kings College London
Speaker: Anastasiois Karadimitris, Imperial College London

5:05 pm-6:35 pm

Room: Hall 1

Three presentations will encompass the spectrum of CD19 CAR T cell research currently ongoing from
•clinical trials using off the shelf (genome edited) T-cells
•translational research using next generation CAR approaches such as armoured CAR T-cells
•basic research involving the use of alternative immune effector populations (NKT cells) as host cells for CD19 CARs